ANISHA PATEL: Open Payments
NPI 1366154882 · TEMECULA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$795 in 25 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $446 · 2025 $795
Food & beverage: $645Speaker / faculty: $150
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $162 |
| SANOFI-AVENTIS U.S. LLC | 1 | $150 |
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| Intra-Sana Laboratories | 3 | $81 |
| Dexcom, Inc. | 3 | $69 |
| GlaxoSmithKline, LLC. | 2 | $51 |
| Novo Nordisk Inc | 2 | $45 |
| PFIZER INC. | 1 | $38 |
| ALK-Abello, Inc | 1 | $28 |
| ViiV Healthcare Company | 1 | $27 |
Products named: REPATHA, RELTONE 200 MG, Dexcom G6 Transmitter, SHINGRIX, OTEZLA, BREZTRI, AIRSUPRA, PREVNAR 20.
Industry payments across CA — which companies pay providers there.
